restor3d, a company that specializes in 3D-printed, personalized orthopedic implants, successfully raised $38 million in growth capital to fuel its growth and launch four new product lines in the next two years.

The capital will fuel commercialization efforts for four fully 3D-printed implant systems: the Veritas shoulder, iTotal Identity knee, Kinos ankle, and Velora hip cup.

“This funding allows us to further scale our technology, expand access to truly personalized care, and continue setting new standards in orthopedic treatment,” said restor3d founder and CEO Kurt Jacobus. “We are redefining what’s possible in orthopedics to better serve our surgeons and patients.”

Here’s more info on the products to watch out for:

Veritas reverse total shoulder system

Pending 510(k) approval, this shoulder implant’s patient-specific baseplate lets surgeons optimize the joint center of rotation and fixation. Both the glenoid and humeral implants feature restor3d’s TIDAL technology to promote osseointegration, and instruments come in a single tray.

iTotal Identity 3DP porous cementless total knee

This is touted as the first cementless, patient-specific knee implant system. It was designed for optimal coverage and precise alignment to remove guesswork during surgery, and earned 510(k) clearance last week.

Kinos modular stem total ankle system

The knee implant was designed for the anterior approach to total ankle replacement. The company said this offers better surgical flexibility and a personalized fit. restor3d earned an FDA nod for Kinos late last year.

Velora 3DP porous acetabular system

The latest generation of the company’s porous hip cup, Velora also incorporates TIDAL technology for bone integration. It was designed for long-term stability in hip replacement surgeries, and its 510(k) is pending.

“From the beginning, our mission at restor3d has been to transform orthopedic care through personalized, data-driven solutions,” said Jacobus. “By leveraging advanced 3D printing and AI-driven design, we are restoring mobility and improving lives—whether its helping patients return to work, get back on the golf course, or simply walk without pain. This approach has allowed us to expand market share efficiently, rapidly enter new segments, and drive strong year-over-year growth.